These results suggest that in lesional skin of AD patients, the expression of both SCCA1 and SCCA2 is induced mainly by IL-4 and IL-13 and in some patients, possibly by IL-22 and IL-17 (Figure 3). Here, IL13 is linked to Alzheimer disease.